Aktive Positionen von Alexandre Heraud
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Osivax SAS
 Osivax SAS BiotechnologyHealth Technology Osivax SAS engages in the development of infectious diseases vaccines and immunotherapies based on oligoDOM? proprietary technology. It operates in the influenza vaccine "INFLUENZA - OVX836" business segment. The company was founded by Alexandre Le Vert, Florence Nicolas and Fergal Hill on May 15, 2017 and is headquartered in Lyon, France. | Direktor/Vorstandsmitglied | 01.10.2018 | - |
Karriereverlauf von Alexandre Heraud
Ehemalige bekannte Positionen von Alexandre Heraud
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Xerys Gestion SASU
 Xerys Gestion SASU Investment ManagersFinance Xerys Gestion SASU (Xerys) is a private equity and venture capital firm headquartered in Paris, France. The firm was founded in 2000 by Jacques Simonnet. | Private Equity Investor | 01.01.2014 | 10.01.2018 |
Statistik
International
| Frankreich | 3 |
Operativ
| Private Equity Investor | 1 |
| Director/Board Member | 1 |
Sektoral
| Finance | 2 |
| Health Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
Xerys Gestion SASU
Xerys Gestion SASU Investment ManagersFinance Xerys Gestion SASU (Xerys) is a private equity and venture capital firm headquartered in Paris, France. The firm was founded in 2000 by Jacques Simonnet. | Finance |
Osivax SAS
Osivax SAS BiotechnologyHealth Technology Osivax SAS engages in the development of infectious diseases vaccines and immunotherapies based on oligoDOM? proprietary technology. It operates in the influenza vaccine "INFLUENZA - OVX836" business segment. The company was founded by Alexandre Le Vert, Florence Nicolas and Fergal Hill on May 15, 2017 and is headquartered in Lyon, France. | Health Technology |
- Börse
- Insiders
- Alexandre Heraud
- Erfahrung
